Actinium Pharmaceuticals, Inc. (ATNM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Aug-22 4:55 PM
View: 
Seth Sandesh
Chief Executive Officer
Director
Actinium Pharmaceuticals, I... (ATNM) 17-Aug-22Grant 300,000----5575%
5.38K to 305.38K
07-Mar-19 4:15 PM
View: 
Berger Mark Stanley
Chief Medical Officer
Actinium Pharmaceuticals, I... (ATNM) 05-Mar-19Exercise (in-the money or at-the-money) 3,500$0.60$2,100.0018%
19.0K to 22.5K
21-Feb-19 4:45 PM
View: 
Seth Sandesh
Chairman & CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 21-Feb-19Exercise (in-the money or at-the-money) 8,125$0.60$4,875.005%
153.33K to 161.46K
10-Dec-18 4:10 PM
View: 
O'Loughlin Steve
Principal Financial Officer
Actinium Pharmaceuticals, I... (ATNM) 10-Dec-18Purchase 10,000$0.44$4,350.0039%
25.5K to 35.5K
10-Dec-18 4:14 PM
View: 
Seth Sandesh
Chairman & CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 10-Dec-18Purchase 10,000$0.44$4,372.007%
143.33K to 153.33K
20-Nov-18 5:08 PM
View: 
Ludwig Dale L.
Chief Scientific Officer
Actinium Pharmaceuticals, I... (ATNM) 19-Nov-18Purchase 10,000$0.45$4,499.00100%
0 to 10.0K
17-Jul-18 5:13 PM
View: 
Seth Sandesh
CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 17-Jul-18Purchase 10,000$0.79$7,900.008%
133.33K to 143.33K
15-Jun-18 6:08 PM
View: 
O'Loughlin Steve
Principal Financial Officer
Actinium Pharmaceuticals, I... (ATNM) 15-Jun-18Purchase 12,000$0.50$6,000.0089%
13.5K to 25.5K
20-Apr-18 4:15 PM
View: 
Seth Sandesh
Chairman & CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 19-Apr-18Purchase 5,000$0.38$1,900.004%
128.33K to 133.33K
19-Mar-18 5:04 PM
View: 
Berger Mark Stanley
Chief Medical Officer
Actinium Pharmaceuticals, I... (ATNM) 06-Mar-18Acquisition (other) 14,000$0.50$7,000.00280%
5.0K to 19.0K
08-Mar-18 4:20 PM
View: 
O'Loughlin Steve
Principal Financial Officer
Actinium Pharmaceuticals, I... (ATNM) 06-Mar-18Acquisition (other) 10,000$0.50$5,000.00286%
3.5K to 13.5K
08-Mar-18 4:35 PM
View: 
Seth Sandesh
Chairman & CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 06-Mar-18Acquisition (other) 52,500$0.50$26,250.0069%
75.83K to 128.33K
08-Mar-18 4:32 PM
View: 
Ray Nitya G.
Executive VP
Actinium Pharmaceuticals, I... (ATNM) 06-Mar-18Acquisition (other) 10,000$0.50$5,000.00100%
10.0K to 20.0K
08-Mar-18 4:24 PM
View: 
Steinhart Richard I
Director
Actinium Pharmaceuticals, I... (ATNM) 06-Mar-18Acquisition (other) 7,000$0.50$3,500.00280%
2.5K to 9.5K
01-Mar-18 7:08 AM
View: 
Shetty Ajit
Director
Actinium Pharmaceuticals, I... (ATNM) 28-Feb-18Purchase 22,730$0.43$9,773.90100%
0 to 22.73K
04-Aug-17 4:22 PM
View: 
Ray Nitya G.
Executive Vice President
Actinium Pharmaceuticals, I... (ATNM) 02-Aug-17Purchase 10,000$0.75$7,500.00100%
0 to 10.0K
04-Aug-17 4:35 PM
View: 
Seth Sandesh
Chairman & CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 02-Aug-17Purchase 33,333$0.75$24,999.8078%
42.5K to 75.83K
15-Jun-17 4:56 PM
View: 
Berger Mark Stanley
Chief Medical Officer
Actinium Pharmaceuticals, I... (ATNM) 15-Jun-17Purchase 5,000$1.11$5,550.00100%
0 to 5.0K
15-Jun-17 4:51 PM
View: 
O'Loughlin Steve
Principal Financial Officer
Actinium Pharmaceuticals, I... (ATNM) 15-Jun-17Purchase 3,500$1.17$4,095.00100%
0 to 3.5K
15-Jun-17 4:54 PM
View: 
Seth Sandesh
Chairman and CEO
Director
Actinium Pharmaceuticals, I... (ATNM) 15-Jun-17Purchase 7,500$1.16$8,725.0021%
35.0K to 42.5K
03-Jan-17 8:00 AM
View: 
Seth Sandesh
Executive Chairman
Director
Actinium Pharmaceuticals, I... (ATNM) 30-Dec-16Purchase 5,000$0.88$4,400.0017%
30.0K to 35.0K
12-Dec-16 4:44 PM
View: 
Seth Sandesh
Executive Chairman
Director
Actinium Pharmaceuticals, I... (ATNM) 12-Dec-16Purchase 5,000$0.98$4,900.0020%
25.0K to 30.0K
01-Sep-16 5:01 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 31-Aug-16Sale 136,853$1.83$251,118.00(3%)
4.85M to 4.71M
01-Sep-16 5:01 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 30-Aug-16Sale 56,074$1.81$101,254.00(1%)
4.9M to 4.85M
30-Aug-16 5:07 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 29-Aug-16Sale 25,000$1.72$42,875.00(< 1%)
4.93M to 4.9M
30-Aug-16 5:07 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 26-Aug-16Sale 25,000$1.70$42,620.00(< 1%)
4.95M to 4.93M
17-Aug-16 4:05 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 16-Aug-16Sale 5,029$1.72$8,651.88(< 1%)
4.96M to 4.95M
17-Aug-16 4:05 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 15-Aug-16Sale 4,439$1.72$7,635.08(< 1%)
4.96M to 4.96M
14-Jul-16 4:29 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 12-Jul-16Sale 3,100$1.80$5,581.00(< 1%)
4.97M to 4.96M
12-Jul-16 5:11 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 11-Jul-16Sale 800$1.80$1,440.00(< 1%)
4.97M to 4.97M
12-Jul-16 5:11 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 08-Jul-16Sale 21,190$1.80$38,142.00(< 1%)
4.99M to 4.97M
07-Jul-16 4:24 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 06-Jul-16Sale 10,500$1.80$18,900.00(< 1%)
5.0M to 4.99M
07-Jul-16 4:24 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 05-Jul-16Sale 10,340$1.82$18,862.20(< 1%)
5.01M to 5.0M
05-Jul-16 4:36 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 01-Jul-16Sale 128,950$1.81$233,897.00(3%)
5.14M to 5.01M
05-Jul-16 4:36 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 30-Jun-16Sale 19,150$1.80$34,539.20(< 1%)
5.16M to 5.14M
17-Jun-16 4:35 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 15-Jun-16Sale 33,619$1.90$63,876.10(< 1%)
5.19M to 5.16M
06-Jun-16 7:20 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 02-Jun-16Sale 17,790$2.01$35,715.80(< 1%)
5.21M to 5.19M
02-Jun-16 4:21 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 01-Jun-16Sale 40,114$2.09$83,837.70(< 1%)
5.25M to 5.21M
02-Jun-16 4:21 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 31-May-16Sale 129,336$1.93$249,547.00(2%)
5.38M to 5.25M
31-May-16 6:58 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 26-May-16Sale 40,068$1.92$77,060.60(< 1%)
5.42M to 5.38M
26-May-16 5:43 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 25-May-16Sale 36,400$1.90$69,235.50(< 1%)
5.45M to 5.42M
26-Apr-16 5:25 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 26-Apr-16Sale 6,500$1.96$12,725.00(< 1%)
5.46M to 5.45M
26-Apr-16 5:25 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 25-Apr-16Sale 18,385$2.02$37,204.00(< 1%)
5.48M to 5.46M
26-Apr-16 5:25 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 22-Apr-16Sale 27,692$2.07$57,336.20(< 1%)
5.51M to 5.48M
21-Apr-16 4:56 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 21-Apr-16Sale 13,000$2.04$26,557.00(< 1%)
5.52M to 5.51M
21-Apr-16 4:56 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 20-Apr-16Sale 33,497$2.03$68,041.60(< 1%)
5.55M to 5.52M
21-Apr-16 4:56 PM
View: 
Memorial Sloan-Kettering Ca...
10% Owner
Actinium Pharmaceuticals, I... (ATNM) 19-Apr-16Sale 150,000$2.03$304,321.00(3%)
5.7M to 5.55M
18-Apr-16 5:26 PM
View: 
Seth Sandesh
Director
Actinium Pharmaceuticals, I... (ATNM) 18-Apr-16Purchase 6,500$1.98$12,885.0035%
18.5K to 25.0K
18-Apr-16 5:26 PM
View: 
Seth Sandesh
Director
Actinium Pharmaceuticals, I... (ATNM) 15-Apr-16Purchase 3,500$2.00$7,015.0023%
15.0K to 18.5K
18-Apr-16 5:24 PM
View: 
Traversa Sergio
Director
Actinium Pharmaceuticals, I... (ATNM) 15-Apr-16Purchase 1,000$2.02$2,020.0050%
2.0K to 3.0K